Nexalis Therapeutics Ltd (NX1) Stock Price & News

All values in AUD	სექ. 2025	დეკ. 2025	მარ. 2026	ივნ. 2026
Revenue	217,49 ათ.	217,49 ათ.	315,05 ათ.	315,05 ათ.
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	376,83 ათ.	376,83 ათ.	637,88 ათ.	637,88 ათ.
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	182,51 ათ.	182,51 ათ.	235,88 ათ.	235,88 ათ.
Operating expense	559,06 ათ.	559,06 ათ.	903,79 ათ.	903,79 ათ.
Total operating expenses	559,06 ათ.	559,06 ათ.	903,79 ათ.	903,79 ათ.
Operating income	-341,56 ათ.	-341,56 ათ.	-588,73 ათ.	-588,73 ათ.
Other non operating income	-	-	-	-
EBT including unusual items	-382,22 ათ.	-382,22 ათ.	-648,97 ათ.	-648,97 ათ.
EBT excluding unusual items	-382,22 ათ.	-382,22 ათ.	-648,97 ათ.	-648,97 ათ.
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-13,90 ათ.	-13,90 ათ.	29,15 ათ.	29,15 ათ.
Net income	-382,22 ათ.	-382,22 ათ.	-648,97 ათ.	-648,97 ათ.
Net profit margin	-175,74%	-175,74%	-205,99%	-205,99%
Earnings per share	-	-	-	-
Interest and investment income	32,00	32,00	537,00	537,00
Interest expense	-40,69 ათ.	-40,69 ათ.	-60,77 ათ.	-60,77 ათ.
Net interest expenses	-40,66 ათ.	-40,66 ათ.	-60,24 ათ.	-60,24 ათ.
Depreciation and amortization charges	-	-	877,00	877,00
EBITDA	-	-	-587,86 ათ.	-587,86 ათ.
Gain or loss from assets sale	-	-	-	-

Finance